Deepshekhar Gupta
Education
M.S., health informatics, Weill Cornell Graduate School of Medical Sciences; B.A., economics, Cornell University
Summary of Experience
Mr. Gupta specializes in the application of statistical models and quantitative research methods to evaluate health outcomes, assess the value of cutting-edge therapies in pharmaceutical and medical device markets, and support assessments of complex questions in health care litigation. His experience in health economics and outcomes research (HEOR) includes modeling differences in health care resource utilization and costs between patient cohorts, assessing the patient treatment journey, modeling survival outcomes, as well as analyzing clinical trial data. He also has experience conducting targeted literature reviews and supporting economic modeling and market access strategy cases. In his litigation work, Mr. Gupta has supported experts in assessing economic harm accruing to parties in payer-policyholder and payer-provider disputes. Mr. Gupta has experience analyzing a wide range of datasets, including commercial and public administrative claims, electronic medical records, and clinical trial data.
- 
                                                        Real-world evidence of Pressure-Enabled Drug Delivery for trans-arterial chemoembolization and radioembolization among patients with hepatocellular carcinoma and liver metastasesCurrent Medical Research and Opinion, 2024 
 2024Cook K, Gupta D, Liu Y, Miller-Rosales C, Wei F, Tuttle E, Katz SC, Marshak R, Kim AY 
- 
                                                        Herpes zoster burden in patients with asthma: real-world incidence, healthcare resource utilisation and costBMJ Open Respiratory Research, 2024 
 2024Singer D, Thompson-Leduc P, Ma S, Gupta D, Cheng WY, Muthukumar A, Devine F, Sundar M, Bogart M, Hagopian E, Poston S, Duh MS, Oppenheimer JJ 
- 
                                                        Burden of Herpes Zoster Among Patients with Psoriatic Arthritis in the United StatesPsoriasis: Targets and Therapy, 2024 
 2024Singer D, Thompson-Leduc P, Ma S, Gupta D, Cheng WY, Sendhil SR, Sundar M, Hagopian E, Stempniewicz N, Duh MS, Poston S 
- 
                                                        Real-world evidence of eteplirsen treatment effects in patients with Duchenne muscular dystrophy in the USAJournal of Comparative Effectiveness Research, 2023 
 2023
- 
                                                        Incidence and Risk of Herpes Zoster in Patients with Ulcerative Colitis and Crohn's Disease in the USAGastroenterology Report, 2023 
 2023Singer D, Thompson-Leduc P, Gupta D, Cheng WY, Poston S, Ma S, Pawlowski JE, Duh MS, Morris ED, Devine F, Farraye FA 
- 
                                                        Economic and Clinical Burden of Herpes Zoster Among Patients With Inflammatory Bowel Disease in the United StatesCrohn's & Colitis 360, 2023 
 2023Singer D, Thompson-Leduc P, Gupta D, Poston S, Cheng WY, Ma S, Pawlowski JE, Duh MS, Devine F, Banatwala A, Bernstein E, Farraye FA 
- 
                                                        Incidence of Herpes Zoster in Patients with Rheumatoid Arthritis in the United States: A Retrospective Cohort StudyJournal of Rheumatology, 2023 
 2023Singer D, Thompson-Leduc P, Poston S, Gupta D, Cheng WY, Ma S, Devine F, Duh MS, Curtis JR 
- 
                                                        Burden of Herpes Zoster Among Patients with Psoriasis in the United StatesDermatology and Therapy, 2023 
 2023Singer D, Thompson-Leduc P, Ma S, Gupta D, Cheng WY, Sendhil SR, Sundar M, Hagopian E, Stempniewicz N, Duh MS, Poston S 
- 
                                                        Clinical and Economic Burden of Herpes Zoster in Patients with Rheumatoid Arthritis: A Retrospective Cohort Study Using Administrative ClaimsRheumatology and Therapy, 2023 
 2023Singer D, Thompson-Leduc P, Poston S, Gupta D, Cheng WY, Ma S, Devine F, Enrique A, Duh MS, Curtis JR 
- 
                                                        Disease Progression Stages and Burden in Patients with Duchenne Muscular Dystrophy Using Administrative Claims Supplemented by Electronic Medical RecordsAdvances in Therapy, 2022 
 2022Iff J, Zhong Y, Gupta D, Paul X, Tuttle E, Henricson E, Schrader R, CINRG DNHS Investigators 
- 
                                                        National and regional description of healthcare measures among adult Medicaid beneficiaries with schizophrenia within the United StatesJournal of Medical Economics, 2022 
 2022Patel C, Pilon D, Gupta D, Morrison L, Lafeuille MH, Lefebvre P, Benson C 
- 
                                                        A Matching-Adjusted Indirect Comparison of Single-Arm Trials in Patients with Relapsed or Refractory Follicular Lymphoma Who Received at Least Two Prior Systemic Treatments: Tazemetostat was Associated with a Lower Risk for Safety Outcomes Versus the PI3-Kinase Inhibitors Idelalisib, Duvelisib, Copanlisib, and UmbralisibAdvances in Therapy, 2022 
 2022Proudman D, Nellesen D, Gupta D, Adib D, Yang J, Mamlouk K 
- 
                                                        Effects of metreleptin in patients with lipodystrophy with and without baseline concomitant medication useCurrent Medical Research and Opinion, 2021 
 2021Adamski K, Cook K, Gupta D, Morris E, Tuttle E, Carr E, Cremasco F, Cochran E, Brown RJ 
- 
                                                        Healthcare resource utilization and costs associated with postpartum depression among commercially insured householdsCurrent Medical Research and Opinion, 2020 
 2020Epperson CN, Huang M, Cook K, Gupta D, Chawla A, Greenberg PE, Eldar-Lissai A 
- 
                                                        Healthcare resource utilization and costs associated with first-line ibrutinib compared to chemoimmunotherapy treatment among Medicare beneficiaries with chronic lymphocytic leukemiaCurrent Medical Research and Opinion, 2020 
 2020Huang Q, Emond B, Lafeuille MH, Gupta D, Lefebvre P, Sundaram M, Mato A 
